AspergillusOne-Health: Deciphering Azole Resistance in Aspergillus Fungi Using a One Health Approach
NCT06532227 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2025-05-23
Summary
During a two year prospective study onpatients from department's hospitals and centralized by the pneumology department Nantes CH,all respiratory clinical samples will be cultivated for Aspergillus isolation (2900Aspergillusisolates) as standard care. The azole susceptibility pattern of isolates will be determined to itraconazole, voriconazole by subculture on azole- enriched medium at 35°c as primary screen and resistance confirmed by EUCAST Reference metho.In parallel, the relevance of detecting resistance (TR34 and TR46) directly in culture-negative BAL respiratory samples by a qPCR method will be studied in an attempt to reach a greater exhaustiveness of the resistance phenomeno. In case of azole-resistant isolate,patient data such as the underlying disease,date and site of Aspergillus isolation,disease classification,previous azole drug exposure,and home and work geographic allocation,occupation of the patient will be collecte. For all other aspergillus occurrences, underlying disease, previous azole drug exposure,home and work location of the patient will be collected in an attempt to identify risk factor.
Conditions
- Aspergillus Fumigatus Infection
Interventions
- OTHER
-
No intervention
No intervention excepted data collection
Sponsors & Collaborators
-
Nantes University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-01
- Primary Completion
- 2026-09-01
- Completion
- 2028-08-01
More Related Trials
-
Voriconazole For Chronic Bronchopulmonary Aspergillosis
NCT00159822 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Detection of Azole Resistance Inducing Mutations on DNA Extracted Directly From Serum or Plasma of Immunocompromised Patients With an Invasive Aspergillus Infection Azole Resistance PCR Optimalization-study
NCT06069505 ·Status: RECRUITING
-
Prophylaxis of Fungal Invasive Infections in Leukemia
NCT00501098 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Impact of Fungal Domestic Environmental Exposure on COPD Patients
NCT02318524 ·Status: COMPLETED
-
Early Diagnosis of Invasive Lung Aspergillosis
NCT05860387 ·Status: RECRUITING
-
Pharmacokinetics of Voriconazole in Adult ECMO Patients
NCT04868188 ·Status: COMPLETED
-
Prospective Multicenter Evaluation of the MycoGenie Kit for the Diagnosis of Invasive Aspergillosis
NCT03349931 ·Status: COMPLETED
-
The Assessment of Antimicrobial Peptides Against Fungal Infection
NCT05368948 ·Status: UNKNOWN
-
A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma
NCT00005668 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnostic and Management Strategies for Invasive Aspergillosis
NCT00816088 ·Status: COMPLETED
-
Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis
NCT00923832 ·Status: COMPLETED
-
A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects
NCT00940017 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence of Influenza RelAted Invasive Aspergillosis
NCT04172610 ·Status: COMPLETED
-
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
NCT00412893 ·Status: COMPLETED ·Phase: PHASE3
-
Immunomonitoring of Mold Invasive Infections
NCT06285188 ·Status: RECRUITING
-
Itraconazole Therapy In Bronchiectasis With Airway Mold
NCT07283497 ·Status: RECRUITING ·Phase: PHASE4
-
CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients
NCT02100761 ·Status: UNKNOWN
-
Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects
NCT02737371 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)
NCT00620074 ·Status: TERMINATED ·Phase: PHASE4
-
Study of FK463 for the Treatment of Invasive Aspergillosis
NCT00036166 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis
NCT00528190 ·Status: COMPLETED ·Phase: PHASE4
-
ATCF (Azole Therapy in Cystic Fibrosis)
NCT01576315 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Intrabronchial Voriconazole Instillation for Inoperable Pulmonary Aspergilloma
NCT03799809 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Single Ascending Oral Dose Study of F901318
NCT02394483 ·Status: COMPLETED ·Phase: PHASE1
-
The Impact of Rapid Diagnostic Methods in the Diagnosis of Fungal Infections in Intensive Care Units of Assiut University Hospital
NCT05876962 ·Status: UNKNOWN